Stopping the COVID-19 Pandemic: A Review on the Advances of Diagnosis, Treatment, and Control Measures

Table 3

Notable COVID-19 vaccine candidates in clinical trial.

Platform	Vaccine	Company	Stage	Location
RNA	mRNA 1273	Moderna	Phase-I (NCT04283461)	USA
	BNT 162	Pfizer, BioNTech	Phase-I (NCT04380701)	Germany, USA
DNA	INO 4800	Inovio Pharmaceuticals	Phase-I (NCT04336410)	USA
		Korean Institute of Health	Phase-I	South Korea
Lentiviral	LV-SMENP-DC	Shenzhen Genoimmune Medical Institute	Phase-I (NCT04276896)	China
	aAPC vaccine	Shenzhen Genoimmune Medical Institute	Phase-I (NCT04299724)	China
Inactivated	PiCoVacc	Sinovac BioTech	Phase-I (NCT04352608)	China
	COVID-19 vaccine	Wuhan Institute of Biological Products (Sinopharm)	Phase-I	China
Nonreplicating viral vector	ChAdox1 nCoV-19	University of Oxford	Phase-I (NCT04324606)	UK
	Ad5- nCoV	CanSino Biologics	Phase-II (NCT04341389)	China
Live attenuated	BCG vaccine	Max Planck Institute	Phase-III	Germany
	BCG vaccine	Radboud University	Phase-III	Netherlands
	BCG vaccine	Texas A&M University	Phase-IV	USA